Exploring the etiology of haploinsufficiency

BioEssays

Volumn 24, Issue 2, 2002, Pages 175-184

  Veitia, Reiner A ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; DOMINANT GENE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MACROMOLECULE; MUTATION;

ANIMALS; GENE DOSAGE; GENE EXPRESSION REGULATION; GENES, DOMINANT; HUMANS; MACROMOLECULAR SUBSTANCES; MODELS, GENETIC; MUTATION; TRANSCRIPTION FACTORS;

EID: 0036008552     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10023     Document Type: Review

References (60)

1. Human disease genes
2. The molecular basis of dominance
3. Linear theory of enzymatic chains, its application for the analysis of the crossover theorem and of the glycolysis of human erythrocytes
4. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia
5. Expression analysis of endoglin missense and truncation mutations: Insights into protein structure and disease mechanisms
6. SOX10 mutations in patients with Waardenburg-Hirschsprung disease
7. Transcription factor hierarchy in Waardenburg syndrome: Regulation of MITF expression by SOX10 and PAX3
8. Nonsense-mediated decay in health and disease
9. Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly
10. The enhanceosome and transcriptional synergy
11. A mathematical model for synergistic eukaryotic gene activation
12. Enhanceosomes
13. To be or not to be active: The stochastic nature of enhancer action
14. Cell signaling can direct either binary or graded transcriptional responses
15. The dose dependence of glucorticoid-inducible gene expression results from changes in the number of transcriptionally active templates
16. Pax genes-paired feet in three camps
17. Modeling stochastic gene expression: Implications for haploinsufficiency
18. Transcritional enhancers-on/off regulation as an adaptation to silencing in higher eukaryotic nuclei
19. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor
20. Dosage-dependent modification of position-effect variegation in Drosophila
21. Position effect in human genetic disease
22. Donor splice-site mutations in WT1 are responsible for Frasier syndrome
23. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal
24. Campomelic Dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene
25. Dax1 antagonizes Sry action in mammalian sex determination
26. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression
27. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene
28. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome
29. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease
30. Congenital heart disease caused by mutations in the transcription factor Nkx2-5
31. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Cram syndrome
32. The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors
33. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation
34. Monoallelic expression of Pax5: A paradigm for the haploinsufficiency of mammalian Pax genes?
35. The possible effects of the aggregation of the molecules of haemoglobin on its oxygen dissociation curve
36. Thermodynamics of ligand-induced assembly of tubulin
37. Divalent cation-, nucleotide-, and polymerization-dependent changes in the conformation of subdomain 2 of actin
38. A theory of linear and helical aggregations of macromolecules
39. Reduced collagen VI causes Bethlem myopathy: A heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency
40. Variation in the vitreous phenotype of Stickler syndrome can be caused by different amino acid substitutions in the X position of the type II collagen gly-X-Y triple helix
41. In vitro collagen fibril assembly in glycerol solution: Evidence for a helical cooperative mechanism involving microfibrils
42. An elastin gene mutation producing abnormal tropoelastin and abnormal elastic fibres in a patient with autosomal dominant cutis laxa
43. Thermodynamic and hydrodynamic properties of human tropoelastin. Analytical ultracentrifuge and pulsed field-gradient spin-echo nmr studies
44. Novel arterial pathology in mice and humans hemizygous for elastin
45. Mlc1p is a light chain for the unconventional myosin Myo2p in Saccharomyces cerevisiae
46. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy a disease of the sarcomere
47. Prenatal diagnosis of alpha-thalassemia: Clinical application of molecular hybridization
48. Influence of PAX6 gene dosage on development: Over-expression causes severe eye abnormalities
49. Comparison of the complete protein sets of worm and yeast: Orthology and divergence
50. Intron postion correlate with module boundaires in ancient proteins
51. Correlation of DNA exonic regions with protein structural units in haemoglobin
52. A combined algorithm for genome-wide prediction of protein function
53. Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome
54. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation
55. Genomic profiling of drug sensitivities via induced haploinsufficiency
56. The mutational spectrum in Waardenburg syndrome
57. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation
58. WT-1 is required for early kidney development
59. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response
60. The hemoglobin system. VI. The oxygen dissociation curve of hemoglobin